Coccidioidomycosis: A Review of Recent Advances

Clinics in Chest Medicine

Volumn 30, Issue 2, 2009, Pages 241-251

  Ampel, Neil M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Coccidioides; Coccidioidomycosis; Fungi

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; INFLIXIMAB; ITRACONAZOLE; NIKKOMYCIN Z; POSACONAZOLE;

CLIMATE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; DRUG EFFICACY; ECOLOGY; FUNGUS TRANSMISSION; HISTOPATHOLOGY; HISTORY OF MEDICINE; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MEDICAL RESEARCH; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; COCCIDIOIDOMYCOSIS; HUMANS;

EID: 64249092323     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2009.02.004     Document Type: Review

References (92)

1. CDC. Notifiable diseases/deaths in selected cities weekly information. MMWR Morb Mortal Wkly Rep 55 50 (2006) 1365
2. Odds F.C. Coccidioidomycosis: flying conidia and severed heads. Mycologist 17 1 (2003) 37-40
3. Hirschmann J.V. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis 44 9 (2007) 1202-1207
4. In: Smith C.E. (Ed). Reminiscences of the flying chlamydospore and its allies. The second symposium on coccidioidomycosis (1967), University of Arizona Press, Phoenix (AZ) p. xiii-xxii
5. Deresinski S.C. History of coccidioidomycosis: "dust to dust.". In: Stevens D.A. (Ed). Coccidioidomycosis a text (1980), Plenum Medical Book Company, New York 1-20
6. Thorne W.S. A case of protozoic skin disease. Occidental Medical Times 8 12 (1894) 703-704
7. Rixford E. A case of protozoic dermatitis. Occidental Medical Times 8 12 (1894) 704-707
8. Rixford E., and Gilchrist T.C. Two cases of protozoon (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep 1 (1896) 209-268
9. Dickson E.C. Primary coccidioidomycosis. The initial acute infection which results in coccidioidal granuloma. Ann Rev Tuberc 38 (1938) 722-729
10. Dickson E.C., and Gifford M.A. Coccidioides infection (coccidioidomycosis). II. The primary type of infection. Arch Intern Med 62 (1938) 853-871
11. Smith C.E., Beard R.R., Whiting E.G., et al. Varieties of coccidioidal infection. Am J Public Health 36 (1946) 1394-1402
12. Ophüls W. Further observations on a pathogenic mould formerly described as a protozoan (Coccidioides immitis; Coccidioides pyogenes). J Exp Med 6 (1905) 443-485
13. Bowman B., Taylor J.W., and White T.J. Molecular evolution of the fungi: human pathogens. Mol Biol Evol 9 5 (1992) 893-904
14. Pan S., Sigler L., and Cole G. Evidence for a phylogenetic connection between Coccidioides immitis and Uncinocarpus reesii (Onygenaceae). Microbiology 140 6 (1994) 1481-1494
15. Burt A., Carter D.A., Koenig G.L., et al. Molecular markers reveal cryptic sex in the human pathogen Coccidioides immitis. Proc Natl Acad Sci U S A 93 (1996) 770-773
16. Koufopanou V., Burt A., Szaro T., et al. Gene genealogies, cryptic species, and molecular evolution in the human pathogen Coccidioides immitis and relatives (Ascomycota, Onygenales). Mol Biol Evol 18 7 (2001) 1246-1258
17. Mandel M.A., Barker B.M., Kroken S., et al. Genomic and population analyses of the mating type loci in Coccidioides species reveal evidence for sexual reproduction and gene acquisition. Eukaryot Cell 6 7 (2007) 1189-1199
18. Fisher M., Koenig G., White T., et al. Pathogenic clones versus environmentally driven population increase: analysis of an epidemic of the human fungal pathogen Coccidioides immitis. J Clin Microbiol 38 2 (2000) 807-813
19. Fisher M., Koenig G., White T., et al. Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration. Proc Natl Acad Sci U S A 98 (2001) 4558-4562
20. Fisher M., Koenig G., White T., et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycol Soc America (2002) 73-84
21. Barker B.M., Jewell K.A., Kroken S., et al. The population biology of Coccidioides: epidemiologic implications for disease outbreaks. Ann N Y Acad Sci 1111 (2007) 147-163
22. Stewart R.A., and Meyer K.F. Isolation of Coccidioides immitis (Stiles) from the soil. Proc Soc Exp Biol Med 29 (1932) 937-938
23. Greene D.R., Koenig G., Fisher M.C., et al. Soil isolation and molecular identification of Coccidioides immitis. Mycologia 92 3 (2000) 406-410
24. Petersen L.R., Marshall S.L., Barton-Dickson C., et al. Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis 10 4 (2004) 637-642
25. Fisher F.S., Bultman M.W., Jonhson S.M., et al. Coccidioides niches and habitat parameters in the southwestern United States. A matter of scale. Ann N Y Acad Sci 1111 (2007) 47-72
26. Kolivras K.N., and Comrie A.C. Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int J Biometeorol 47 2 (2003) 87-101
27. Park B.J., Sigel K., Vaz V., et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 191 11 (2005) 1981-1987
28. Valley fever annual report 2007 (2008), Arizona Department of Health Services
29. Ampel N.M., Mosley D.G., England B., et al. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 27 6 (1998) 1528-1530
30. Leake J.A., Mosley D.G., England B., et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 181 4 (2000) 1435-1440
31. Sunenshine R.H., Anderson S., Erhart L., et al. Public health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci 1111 (2007) 96-102
32. Beaman L., Holmberg C., Henrickson R., et al. The incidence of coccidioidomycosis among nonhuman primates housed outdoors at the California Primate Research Center. J Med Primatol 9 4 (1980) 254-261
33. Shubitz L.F., Butkiewicz C.D., Dial S.M., et al. Incidence of Coccidioides infection among dogs residing in a region in which the organism is endemic. J Am Vet Med Assoc 226 11 (2005) 1846-1850
34. Flaherman V.J., Hector R., and Rutherford G.W. Estimating severe coccidioidomycosis in California. Emerg Infect Dis 13 7 (2007) 1087-1090
35. Schneider E., Hajjeh R.A., Spiegel R.A., et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 277 11 (1997) 904-908
36. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 19 Suppl 1 (1994) S14-S18
37. Rosenstein N.E., Emery K.W., Werner S.B., et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 32 5 (2001) 708-715
38. Crum N.F., Potter M., and Pappagianis D. Seroincidence of Coccidioidomycosis during military desert training exercises. J Clin Microbiol 42 10 (2004) 4552-4555
39. Pappagianis D. Coccidioidomycosis in California state correctional institutions. Ann N Y Acad Sci 1111 (2007) 103-111
40. McKinley J. Infection hits a California prison hard. The New York Times (2007)
41. Ampel N.M. Measurement of cellular immunity in human coccidioidomycosis. Mycopathologia 156 4 (2003) 247-262
42. Ampel N.M., Kramer L.A., Li L., et al. In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K. Clin Diagn Lab Immunol 9 5 (2002) 1039-1043
43. Catanzaro A., Spitler L.E., and Moser K.M. Cellular immune response in coccidioidomycosis. Cell Immunol 15 2 (1975) 360-371
44. Cox R.A., Brummer E., and Lecara G. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a Coccidioides cell wall antigen. Infect Immun 15 3 (1977) 751-755
45. Richards J.O., Ampel N.M., and Lake D.F. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 169 4 (2002) 2020-2025
46. Dionne S.O., Podany A.B., Ruiz Y.W., et al. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation. Infect Immun 74 4 (2006) 2415-2422
47. Modlin R.L., Segal G.P., Hofman F.M., et al. In situ localization of T lymphocytes in disseminated coccidioidomycosis. J Infect Dis 151 2 (1985) 314-319
48. Li L., Dial S.M., Schmelz M., et al. Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis. Infect Immun 73 7 (2005) 3923-3928
49. Tsai M.C., Chakravarty S., Zhu G., et al. Characterization of the Tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8 2 (2006) 218-232
50. Marchal-Somme J., Uzunhan Y., Marchand-Adam S., et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 176 10 (2006) 5735-5739
51. Cole G.T., Xue J.M., Okeke C.N., et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 42 3 (2004) 189-216
52. Shubitz L., Peng T., Perrill R., et al. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect Immun 70 6 (2002) 3287-3289
53. Shubitz L.F., Yu J.J., Hung C.Y., et al. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine 24 31-32 (2006) 5904-5911
54. Shubitz L.F., Dial S.M., Perrill R., et al. Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun 76 (2008) 5553-5564
55. Tarcha E.J., Basrur V., Hung C.Y., et al. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice. Infect Immun 74 1 (2006) 516-527
56. Tarcha E.J., Basrur V., Hung C.Y., et al. Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun 74 10 (2006) 5802-5813
57. Herr R.A., Hung C.Y., and Cole G.T. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis. Infect Immun 75 12 (2007) 5777-5787
58. Blair J.E., and Currier J.T. Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia 166 2 (2008) 77-82
59. Kuberski T., Myers R., Wheat L.J., et al. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis 44 5 (2007) e50-e54
60. Durkin M., Connolly P., Kuberski T., et al. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis 47 8 (2008) e69-e73
61. Bialek R., Kern J., Herrmann T., et al. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J Clin Microbiol 42 2 (2004) 778-783
62. de Aguiar Cordeiro R., Nogueira Brilhante R.S., Gadelha Rocha M.F., et al. Rapid diagnosis of coccidioidomycosis by nested PCR assay of sputum. Clin Microbiol Infect 13 4 (2007) 449-451
63. Brilhante R.S., Cordeiro R.A., Rocha M.F., et al. Coccidioidal pericarditis: a rapid presumptive diagnosis by an in-house antigen confirmed by mycological and molecular methods. J Med Microbiol 57 Pt 10 (2008) 1288-1292
64. Ampel N.M., Dols C.L., and Galgiani J.N. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 94 3 (1993) 235-240
65. Woods C.W., McRill C., Plikaytis B.D., et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 181 4 (2000) 1428-1434
66. Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV infection in the age of potent antiretroviral therapy: a cohort analysis. Annual Meetings of the 48th ICAAC/46th IDSA Meeting; Washington, DC, 2008.
67. Winthrop K.L., Yamashita S., Beekmann S.E., et al. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis 46 11 (2008) 1738-1740
68. Bergstrom L., Yocum D.E., Ampel N.M., et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum 50 6 (2004) 1959-1966
69. Blair J.E., Kusne S., Carey E.J., et al. The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Transplantation 83 9 (2007) 1182-1187
70. Blair J.E. Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis 21 4 (2008) 415-420
71. Wright P.W., Pappagianis D., Wilson M., et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 37 9 (2003) 1265-1269
72. Blair J.E., and Mulligan D.C. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis 9 1 (2007) 78-82
73. Muir Bowers J., Mourani J.P., and Ampel N.M. Fatigue in coccidioidomycosis. Quantification and correlation with clinical, immunological, and nutritional factors. Med Mycol 44 7 (2006) 585-590
74. Blair J.E., Mayer A.P., Currier J., et al. Coccidioidomycosis in elderly persons. Clin Infect Dis 47 (2008) 1513-1518
75. Galgiani J.N., Ampel N.M., Blair J.E., et al. Coccidioidomycosis. Clin Infect Dis 41 9 (2005) 1217-1223
76. Galgiani J.N., Catanzaro A., Cloud G.A., et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med 133 9 (2000) 676-686
77. Gonzalez G.M., Tijerina R., Najvar L.K., et al. In vitro and in vivo activities of posaconazole against Coccidioides immitis. Antimicrobial Agents Chemother 46 5 (2002) 1352-1356
78. Anstead G.M., Corcoran G., Lewis J., et al. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 40 12 (2005) 1770-1776
79. Catanzaro A., Cloud G.A., Stevens D.A., et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis 45 5 (2007) 562-568
80. Stevens D.A., Rendon A., Gaona-Flores V., et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest 132 3 (2007) 952-958
81. Cortez K.J., Walsh T.J., and Bennett J.E. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 36 12 (2003) 1619-1622
82. Prabhu R.M., Bonnell M., Currier B.L., et al. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis 39 7 (2004) e74-e77
83. Proia L.A., and Tenorio A.R. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrobial Agents Chemother 48 6 (2004) 2341
84. Fiese M.J. Treatment of disseminated coccidioidomycosis with amphotericin B: report of a case. Calif Med 86 (1957) 119-120
85. Gonzalez G.M., Tijerina R., Sutton D.A., et al. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. Antimicrobial Agents Chemother 46 5 (2002) 1583-1585
86. Clemons K.V., Sobel R.A., Williams P.L., et al. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrobial Agents Chemother 46 8 (2002) 2420-2426
87. Antony S. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 39 6 (2004) 879-880
88. Hsue G., Napier J.T., Prince R.A., et al. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 54 1 (2004) 292-294
89. Gonzalez G.M., Gonzalez G., Najvar L.K., et al. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model. J Antimicrob Chemother 60 6 (2007) 1341-1346
90. Hector R.F., Zimmer B.L., and Pappagianis D. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrobial Agents Chemother 34 4 (1990) 587-593
91. Galgiani J.N. Coccidioidomycosis: changing perceptions and creating opportunities for its control. Ann N Y Acad Sci 1111 (2007) 1-18
92. Ampel N.M., Giblin A., Mourani J.P., et al. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis 48 (2009) 172-178